-
Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myeloma
Seefat, M. R., Cucchi, D. G. J., van Boven, L., Durdu-Rayman, N., Groen, K., Levin, M. D., de Heer, K., de Valk, B., Wester, R., van der Spek, E., Rentenaar, R., Korst, C. L. B. M., Quik, M., O'Neill, C. A., Tzortzi, P., Smits, F., Mathot, R., Heerma van Voss, M. R., van de Donk, N. W. C. J. & Mutis, T. & 2 others, , 2025, (E-pub ahead of print) In: British Journal of Haematology.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Preclinical activity of allogeneic SLAMF7-specific CAR T-cells (UCARTCS1) in multiple myeloma
Korst, C. L. B. M., O'Neill, C., Bruins, W. S. C., Cosovic, M., Twickler, I., Verkleij, C. P. M., le Clerre, D., Themeli, M., Chion-Sotinel, I., Zweegman, S., Galetto, R., Mutis, T. & van de Donk, N. W. C. J., 25 Jul 2024, In: Journal for Immunotherapy of Cancer. 12, 7, e008769.Research output: Contribution to journal › Article › Academic › peer-review
-
T-Cell Characteristics Impact Response and Resistance to T-Cell-Redirecting Bispecific Antibodies in Multiple Myeloma
Verkleij, C. P. M., O'Neill, C. A., Broekmans, M. E. C., Frerichs, K. A., Bruins, W. S. C., Duetz, C., Kruyswijk, S., Baglio, S. R., Skerget, S., de Oca, R. M., Zweegman, S., Verona, R. I., Mutis, T. & van de Donk, N. W. C. J., 15 Jul 2024, In: Clinical Cancer Research. 30, 14, p. 3006-3022 17 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
